Progyny Inc

11 sept. 2026, 20:08 UTC

Progyny Inc shares are higher during Friday's session, despite no specific news. The broader market has closed lower, reflecting a cumulative gain since Thursday.

10 sept. 2026, 20:07 UTC

Progyny Inc shares are lower today amid broader market declines and rising Treasury yields. No specific company news has been identified to explain the move.

9 sept. 2026, 20:07 UTC

Progyny Inc shares are lower in Wednesday trading, reflecting broader market trends. Earlier, they pulled back from a session low before recovering somewhat.

8 sept. 2026, 20:02 UTC

Citizens raised its price target on Progyny to $33, contributing to positive sentiment. The company reported Q2 revenues of $350.5 million.

3 sept. 2026, 20:07 UTC

Progyny Inc. shares are higher as CFO Mark Livingston prepares to present at the Wells Fargo Healthcare Conference on September 8, 2026.

2 sept. 2026, 20:08 UTC

Progyny Inc shares are higher today, continuing gains since Tuesday's close. The stock peaked earlier in the session before settling back.

1 sept. 2026, 23:41 UTC

Progyny Inc shares are higher in after-market hours, though no specific news was identified. The stock remains near its one-month range's lower end.

31 aug. 2026, 20:07 UTC

Progyny Inc. shares are lower as market sentiment shifts amid expectations of further interest rate hikes following the Jackson Hole Economic Symposium.

26 aug. 2026, 20:08 UTC

Progyny Inc shares are higher during Wednesday's session, continuing a notable gain since Tuesday. The stock remains below its 20-day moving average.

25 aug. 2026, 19:36 UTC

Progyny Inc. shares are advancing after reporting Q2 revenue growth of 5.3% and projecting full-year revenue between $1.36 billion and $1.385 billion.

24 aug. 2026, 19:36 UTC

Progyny Inc shares are lower today, reversing from earlier gains amid market volatility linked to geopolitical tensions and US sanctions against Iran.

20 aug. 2026, 19:31 UTC

Wells Fargo initiated coverage on Progyny Inc with an Overweight rating and a $37.00 price target, contributing to the stock's rise during Thursday's session.

18 aug. 2026, 20:06 UTC

Progyny Inc. shares are higher today, reflecting steady gains during the session. The stock remains below its 20-day moving average.

17 aug. 2026, 20:01 UTC

Progyny Inc shares are lower following a negative market reaction to its second-quarter earnings and lowered full-year revenue guidance to $1.37 billion.

14 aug. 2026, 20:06 UTC

Progyny Inc shares are higher during Friday's session, despite a recent pullback from earlier highs. Broader market sentiment remains mixed amid declining U.S. retail sales.

13 aug. 2026, 21:31 UTC

Progyny Inc shares are higher in after-market trading, recovering from earlier losses. No specific news was identified to explain the price movement.

12 aug. 2026, 20:01 UTC

Progyny Inc shares are lower following a Barclays downgrade, which cut the price target to $30 from $34, citing performance concerns.

11 aug. 2026, 20:02 UTC

Progyny Inc's stock is declining after a disappointing revenue forecast, despite strong second-quarter results that exceeded analyst expectations.

7 aug. 2026, 20:02 UTC

Progyny Inc's shares are lower after a cautious Q3 sales outlook, despite reporting revenue of $350.5 million that exceeded analyst expectations.

6 aug. 2026, 23:02 UTC

Progyny Inc shares are lower in after-market trading following a revenue guidance cut to $1.36 billion to $1.39 billion, below previous estimates.

31 iul. 2026, 19:46 UTC

Progyny Inc shares are lower today amid broader market pressures and rising bond yields. No specific company news was identified to explain the decline.

30 iul. 2026, 21:02 UTC

Progyny Inc shares are lower in after-market hours, with no specific news identified for the decline. The stock is below its 20-day moving average.

29 iul. 2026, 18:55 UTC

Progyny Inc shares are higher today, reflecting notable strength in trading. The stock remains above its 20-day moving average.

28 iul. 2026, 17:41 UTC

Progyny Inc shares are lower following a downgrade by Barclays, which noted slowing website traffic growth at fertility clinics. Price target raised to $34 from $27.

24 iul. 2026, 15:06 UTC

BTIG maintained its Buy rating on Progyny and raised the price target to $40. Shares are trading higher, remaining above the 20-day moving average.

22 iul. 2026, 20:01 UTC

Progyny Inc shares are lower despite the acceptance of benefits at Pinnacle Fertility New York, enhancing access to reproductive care for members.

20 iul. 2026, 17:16 UTC

Progyny Inc shares are higher today, maintaining a position near their one-month trading range. No specific news was identified to explain the movement.